Indomethacin therapy for patent ductus arteriosus: When is prophylaxis not prophylactic?
- 30 November 1987
- journal article
- editorial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 111 (5) , 718-722
- https://doi.org/10.1016/s0022-3476(87)80248-2
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- 1563 INDOMETHACIN (I) THERAPY IN PREMATURE INFANTS WITH PDA — DETERMINATION OF THERAPEUTIC PLASMA LEVELSPediatric Research, 1985
- Patent ductus arteriosus in neonates with severe respiratory diseaseThe Journal of Pediatrics, 1984
- Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response.Heart, 1983
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Pharmacokinetics of Indomethacin in the NeonateNew England Journal of Medicine, 1981
- Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infantsThe Journal of Pediatrics, 1981
- Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus—a double-blind controlled studyThe Journal of Pediatrics, 1981
- Pharmacokinetics of intravenously administered indomethacin in premature infantsThe Journal of Pediatrics, 1980
- The disposition of indomethacin in preterm babiesThe Journal of Pediatrics, 1980
- Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infantsThe Journal of Pediatrics, 1978